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DA strain of TMEV induces a chronic, persistent, demyelinating disease in SJL/J weanling mice, while inoculation with
GDVII strain of TMEV induces an acute, lethal neurovirulent disease. We show that three amino acids in the DA EF loop —
DAVP2 141 Lys, 143 Gly, and 173 Thr— are part of a neutralization site of DA monoclonal antibody (mAb), DAmAb1. DA
virus with a mutation of VP2 143 from Gly to Asp, like wild-type virus, persists 6 weeks postinfection (PI) and produces
white matter disease. DA virus with a mutation of VP2 141 from Lys to Asn persists but does not induce significant white
matter disease. DA virus with a mutation of DA VP2 173 from Thr to Phe fails to persist or to induce significant white matter
disease. The diversity and complexity of the mutant virus-induced disease phenotype presumably reflects the varied effects
of the mutated amino acid residues on the three-dimensional structure of the viral capsid. The localization of DA VP2 141
and VP2 173 near the putative receptor binding region of the virus suggest that a disruption of interactions between the
virus and its receptor is important in the late demyelinating disease and for virus neutralization. q 1996 Academic Press, Inc.
INTRODUCTION sid proteins are critical for neurovirulence (reviewed in
Roos and Casteel, 1992).
Theiler’s murine encephalomyelitis virus (TMEV) des- An impetus for the present investigations were the
ignates a group of closely related strains of a picornavi- apparently conflicting results from two laboratories work-
rus that cause enteric and central nervous system (CNS) ing with separately prepared recombinant viruses that
disease in weanling mice (reviewed in Roos and Casteel, had the GDVII IB-2A genomic coding region substituted
1992). DA strain and other members of the TO subgroup for the corresponding part of DA (Jarousse et al., 1994).
cause a biphasic disease, initially infecting neurons and The recombinant viruses used had been constructed
then inducing a persistent, demyelinating infection of the from different parental DA and GDVII cDNA clones (Fu
CNS (Lipton, 1975; Lipton and Dal Canto, 1978). The latter et al., 1990; McAllister et al., 1989; Roos et al., 1989;
disease serves as an experimental model of multiple Tangy et al., 1989). Inoculation with GDIB-2A/DAFL3 virus
sclerosis (MS). In contrast, inoculation of weaning mice (the name for the recombinant virus produced by the
with GDVII strain and other members of the GDVII sub- laboratory of Roos and colleagues) induced a persistent
group leads to an acute, fatal polioencephalomyelitis infection with demyelination (Fig. 1) (Jarousse et al.,
(Roos and Casteel, 1992). 1994). In contrast, inoculation with TMR4 virus (the name
To identify viral genes responsible for the different for a presumed identical recombinant virus produced by
phenotypes, investigators have generated full-length in- the laboratory of Brahic and colleagues) neither persisted
fectious cDNA clones of both DA and GDVII and then nor induced demyelination (Fig. 1) (Tangy et al., 1991).
constructed chimeric cDNA clones with parts of DA and Sequencing of these and additional recombinant viruses
GDVII exchanged for one another. The resultant recombi- generated from reagents interchanged between the two
nant viruses have been inoculated into animals to eluci- laboratories resolved the apparent conflict and demon-
date the molecular determinants of neurovirulence, de- strated that the presence of an Asn at DA VP2 141 (in
myelinating activity, and persistence (Pritchard et al., TMR4 virus) rather then a Lys (in the GD1B-2A/DAFL3
1993; Tangy et al., 1991; Zhang et al., 1993). These stud- virus) dramatically attenuated the ability of these recom-
ies have demonstrated, for example, that the GDVII cap- binant viruses to demyelinate and persist (Fig. 1)
(Jarousse et al., 1994). Further studies showed that the
parental DA virus of Roos and colleagues, DAFL3, had1 S. Sato and L. Zhang contributed equally to this study.
a Lys residue at VP2 141, while the parental DA virus of2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (312) 702-7775. E-mail: rroos@drugs.bsd.uchicago.edu. the Brahic group, TMDA, had an Asn at VP2 141 (Jarousse
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FIG. 1. Wild-type and mutant TMEV and their phenotypes. Segments derived from the pDAFL3 parental infectious clone (Roos et al., 1989a) are
shown as open bars; segments derived from the pTMDA parental infectious clone (McAllister et al., 1989) are shown as shaded bars; segments
derived from the pGDVII infectious clone (Fu et al., 1990) are shown as black bars. The TMEV genome organization is shown at the bottom: the
5*UTR and 3*UTR represent the 5* and 3* untranslated regions, respectively; L encodes the leader protein; P1 encodes the precursor for capsid
proteins 1A (VP4), 1B (VP2), 1C (VP3), and 1D (VP1); P2 and P3 encode the precursors for nonstructural proteins. The circle shows the presence
of a Lys (open) or Asn (shaded) as VP2 141 for the topmost 5 viruses; the bottom five viruses all have a Lys as VP2 141 (since they have a DAFL3
backbone), but have a mutant residue elsewhere in VP2 which is specified and shown as a speckled circle. The sensitivity (/) or resistance (0)
of the particular virus to neutralization by DAmAb1 is noted; also see Table 1 and the Results section. The ability of these viruses to induce white
matter pathology (meningitis, inflammation, and demyelination) is scored from / to /// as described under Materials and Methods and derived
from the mean value (see Table 4). The approximate white matter pathology grades of TMDA, GD1B-2A/DAFL3, and TMR4 viruses are taken from
a previous publication (Jarousse et al., 1994). ND  not determined.
et al., 1994); it remained unclear, however, whether the surrounding amino acids in the TO subgroup disease
phenotype.presence of Asn as VP2 141 affected the ability of the
parental DA strain (as well as the recombinant TMR4 The crystallographic three-dimensional structures of
two members of the TO subgroup, DA and BeAn, havevirus) to demyelinate and persist. One of the goals of the
present study was to clarify the role of VP2 141 and been solved (Grant et al., 1992; Luo et al., 1992). The
TABLE 1
DAmAb1 Neutralization of DA and DA Mutantsa
Dilution of DA-VP2-141 DA-VP2-143 DA-VP2-148 DA-VP2-162 DA-VP2-173
DAmAb1 DAFL3 (Asn) (Asp) (Ala) (Ser) (Phe)
1003.0 / 0 0 / / 0
1003.6 / 0 0 / / 0
1004.2 / 0 0 / / 0
1004.8 0 0 0 / / 0
a Neutralization assays were performed by using 100 PFU of either wild-type DAFL3 virus or mutant virus with various dilutions of DAmAb1. The
result was scored as positive if there was a 50% or greater reduction in the number of PFUs.
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TABLE 2
Amino Acid Differences in VP2 ‘‘EF’’ Loop Found in DAmAb1
Escape Mutants Compared to Wild-Type DA Viruses
DAmAb1 escape DAmAb1 escape
VP2 mutant viruses mutant virus
Residue DAFL3a DAPWa Nos. 1 –4 No. 5
143 Gly Gly Asp Gly
148 Thr Thr/Ala Ala Ala
162 Gly Gly/Ser Ser Ser
173 Thr Thr Thr Phe
a DAFL3 virus was derived from transfection of the pDAFL3 wild-type
FIG. 2. One-step growth curves of DAFL3 and mutant viruses on BHK-infectious cDNA clone. DAPW is a wild-type virus stock similar to the
21 cells. The studies were performed as described under Materials andone used as a parent virus to generate 5 escape mutant viruses.
Methods. Results shown are the mean titers from two samples that
were separately assayed from each time point.
three major capsid proteins VP1, VP2, and VP3, have an
eight-stranded antiparallel b-barrel core structure, as is (AAAGGGTCAGCGGGCTCCATG), with a change in
true for other picornaviruses. Unique loop structures that amino acid VP2 148 from Thr to Ala; pDA-VP2-162 (Ser)
connect the b-barrels extend outward into space from (AGTGGGCGCACTTTGCGGGCC), with a change in
the capsid surface and constitute potential antigenic amino acid VP2 162 from Gly to Ser; and pDA-VP2-173
sites. DA VP2 141 is located in the EF loop of VP2 (which (Phe) (GCGAAGAAACCCGAACCGGCTATCGTA), with a
spans VP2 amino acid 136 to 181) and arises from the change in amino acid VP2 173 from Thr to Phe. Each
surface of the virion, suggesting a role for this region primer was annealed in a separate reaction to produce
in virus neutralization—especially since a neutralization a different mutant plasmid. Double-stranded cDNAs were
site in the ‘‘EF loop’’ has been identified in the case of then generated from these single stranded/annealed
Mengo virus, a cardiovirus related to TMEV (Boege et primers and used to transform Supercompetent Esche-
al., 1991). In the present study, we demonstrate that the richia coli cells (Stratagene, La Jolla, CA). The plasmids
EF loop of VP2 contains epitopes for a previously de- were sequenced using the dsDNA sequencing kit
scribed neutralizing monoclonal antibody, DAmAb1 (Ni- (GIBCO BRL, Gaithersburg, MD) to confirm the presence
tayaphan et al., 1985), and is important for the late demye- of the changes.
linating white matter disease.
Preparation of DAmAb1 neutralization escape mutant
MATERIALS AND METHODS viruses
Cells TMEV mAbs were prepared and characterized as pre-
viously described (Nitayaphan et al., 1985). A wild-typeBHK-21 cells (baby hamster kidney cells) were ob-
DA virus stock was plaque-purified three times beforetained from American Type Culture Collection and used
use in the generation of mutant viruses resistant tofor transfection, plaque assays, and the growth of stock
DAmAb1. Mutants were isolated by growing the virusvirus.
with mAb on BHK-21 cells for 4– 7 passages and then
performing a plaque assay in which L cells were infectedConstruction of mutant plasmids
with serial 10-fold dilution of the resistant virus and then
The template for the construction of mutants was the
full-length, infectious cDNA clone of DA strain known as
TABLE 3pDAFL3 (Roos et al., 1989a). pDAFL3 was made into
a full-length, single stranded, uracil-containing template Virus Titer in the Brain at 1 Week Postinoculation
according to methods provided in a Muta-gene kit (Bio-
TiterRad, Hercules, CA). The mutant plasmids that were con-
Virus (PFU/g)structed (and the oligonucleotide primer used for the
mutagenesis reaction (Operon, Alameda, CA) shown 5*- DAFL3 2.9 1 104
3* with nucleotide mismatches underlined) are: pDA-VP2- DA-VP2-141 (Asn) 9.0 1 103
DA-VP2-143 (Asp) 7.8 1 103141 (Asn) (CCATGTCACTATTTGTTCC), with a change in
DA-VP2-148 (Ala) 3.0 1 104amino acid VP2 141 from Lys to Asn; pDA-VP2-143 (Asp)
DA-VP2-162 (Ser) 1.4 1 104(GGCTCCATGTCATCAGTCTTTGTTCC), with a change in
DA-VP2-173 (Phe) 4.8 1 103amino acid VP2 143 from Gly to Asp; pDA-VP2-148 (Ala)
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TABLE 4 determined by the GIBCO BRL dsDNA cycle sequencing
kit. Because the original DA parental virus that was usedPathological Findings Following Inoculation of Wild-Type
for generation of the mutant viruses was no longer avail-and Mutant DA Virusesa
able for the present study, we made use of a later pas-
Number with white sage wild-type virus, DAPW, prepared from the original
Virus Mean { SD matter disease/total (%) parent. Later passages of DAPW virus had originally pro-
vided stock for the viral RNA template that was used toDAFL3 2.7 { 0.6 14/15 (93)
prepare the full-length pDAFL3 cDNA infectious cloneDA-VP2-141 (Asn) 0.8 { 0.6** 0/22 (0)
DA-VP2-143 (Asp) 2.0 { 0.6* 7/9 (78) (and transfection-derived DAFL3 virus) (Roos et al.,
DA-VP2-148 (Ala) 1.8 { 0.9* 5/8 (63) 1989a).
DA-VP2-162 (Ser) 2.3 { 0.2 8/8 (100)
DA-VP2-173 (Phe) 0.3 { 0.4** 0/8 (0) Preparation of engineered wild-type and mutant
viruses
a Pathology of animals graded according to Materials and Methods.
Wild-type pDAFL3 or mutant pDAFL3 (see previousThe number of animals with white matter disease represents those
with a grade ⁄2. section) cDNA transcription templates were linearized
* P  0.05 vs DAFL3. by restriction endonuclease XbaI (Boehringer Mannheim
** P  0.001 vs DAFL3. Biochemicals, Indianapolis, IN), which digests 3* to the
terminus of the viral genomic cDNA construct. The cDNA
was then transcribed with T7 RNA polymerase and theoverlaid with a 1:1 mixture of 21 minimal essential me-
dium (GIBCO BRL) and 1% agarose containing a final RNA product was transfected into BHK-21 cells, as pre-
viously published (Roos et al., 1989a). The resultant virusconcentration of 10% DAmAb1, as previously described
(Ohara et al., 1988). The putative mutant virus was was plaque-purified twice and passed an additional two
times in BHK-21 cells to produce a virus stock. Thepassed in BHK-21 cells until the titer was sufficiently high
to carry out the required assays. RNA was extracted with DAFL3 virus stock used in the present study was a wild-
type virus generated from transfection of transcripts de-RNAzol (Biotecx, Houston, TX) and cDNA encoding VP2
was prepared by reverse transcription-polymerase chain rived from pDAFL3. To confirm the presence of the muta-
tion in the virus, RNA was extracted using RNAzol (Bio-reaction (RT-PCR) using the following primers: 5*-AAT-
GCTTTTGCTACTATG and 3*-AGTTGCGGGCAACAG- tecx) and cDNA, prepared by RT-PCR, was analyzed by
an GIBCO BRL dsDNA cycle sequencing kit.CAG. The nucleotide sequence encoding all of VP2 was
FIG. 3. Histopathology of spinal cords harvested 6 weeks after intracerebral inoculation with wild-type DA, DA-VP2-141(Asn), or DA-VP2-173(Phe)
viruses (magnification 1100). The spinal cord from a representative mouse inoculated with wild-type DA virus (a) demonstrates white matter
disruption with an accumulation of inflammatory cells both in the Virchow Robin spaces as well as in the white matter. The spinal cord from a
representative mouse inoculated with (b) DA-VP2-141(Asn) virus, and (c) DA-VP2-173(Phe) virus show minimal pathology.
AID VY 8288 / 6a26$$$122 11-14-96 10:47:54 viras AP: Virology
331DA VP2 NEUTRALIZATION SITE AND DISEASE DETERMINANTS
Neutralization assay 1% agarose and 5% fetal bovine serum in modified Eagle
medium (GIBCO BRL) and incubated for 4– 6 days at
Plaque-reduction neutralization tests were performed 337. After fixation and staining, plaques were counted.
as previously described (Nitayaphan et al., 1985; Roos Neutralization was defined as a reduction in the number
et al., 1989b). Approximately 100 plaque forming units of plaques by greater than 50% of control. A neutralization
(PFU) of parental or mutant virus were incubated for 1 escape mutant was defined as a virus that requires ap-
hr at room temperature in an equal volume of various proximately 101.5-fold more mAb to be neutralized than
dilutions of ascites fluid or hybridoma supernatant con- the same amount of wild-type virus.
taining the respective mAb or an irrelevant mAb that
Animal inoculationserved as a negative control. The virus– antibody mixture
was allowed to adsorb onto BHK-21 cells with rocking Weanling SJL/J mice (Jackson Laboratory, Bar Harbor,
ME) were inoculated intracerebrally with 0.03 ml con-for 1 hr at 337. The cell monolayers were overlaid with
FIG. 3— Continued
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taining 1 1 107 PFU/ml of virus except in the case of amplify the coding region of VP2 (5*-AATGCTTTTGCT-
ACTATG, 3*-GGGGTTTACGGGCTGGAT). The conditionsDAFL3 (1.5 1 107 PFU/ml) and DA-VP2-141(Asn) (4.0 1
108 PFU/ml) viruses. Mice were sacrificed at 1 and 6 of the RT-PCR were as previously described (Zhang et
al., 1995). To ensure that a similar amount of cDNA wasweeks postinoculation (PI) and their brains and spinal
cords were removed for virus assays or histopathology. generated in the RT reaction, PCR was performed on the
same sample using hypoxanthine phosphoribosyl trans-
Quantitative pathologic analysis in spinal cords ferase (HPRT)-specific primers (Reiner et al., 1993).
Spinal cords from at least 8 mice from each group
RESULTSinoculated 6 weeks previously with either wild-type or
DA VP2 141 is part of a neutralization sitemutant virus were fixed in 10% formalin and embedded
in paraffin. Sections of spinal cord were stained with To delineate the importance of VP2 141 as a neutraliza-
hematoxylin and eosin. The pathological findings were tion site of DA virus, DAFL3 VP2 141 Lys was changed
scored usually on at least five spinal cord sections from to Asn by site-directed mutagenesis, and the resultant
each mouse as follows: ‘‘0,’’ no pathology; ‘‘/,’’ meningitis virus, DA-VP2-141 (Asn), was tested in a plaque-reduc-
with not more than one inflammatory infiltrate in the pa- tion neutralization test. Several TMEV neutralizing mAbs
renchyma examined and no disruption of the white mat- that we have described (Nitayaphan et al., 1985) neutral-
ter; ‘‘//,’’ moderate inflammation and white matter dis- ized this mutant virus as efficiently as wild-type virus
ruption (that is present in about half of the white matter (data not shown); however, as shown in Table 1, DAmAb1
parenchyma examined); ‘‘///,’’ severe inflammation neutralized wild-type DAFL3 virus, but failed to neutralize
and white matter disruption (that is present in about 75% DA-VP2-141 (Asn) mutant virus; similar results were ob-
of the white matter parenchyma examined). A mean tained with another mutant virus separately derived from
score and standard deviation (SD) of the white matter a different pDA-VP2-141 (Asn) cDNA clone. These results
disease was determined for each group of mice inocu- suggested that VP2 141 is part of an epitope of DAmAb1.
lated with wild-type or mutant virus by setting the grade
of ‘‘0’’ through ‘‘///’’ equivalent to ‘‘0’’ through ‘‘3.’’ Statis- DAmAb1 escape mutant viruses have changes in the
tical comparisons were performed according to the VP2 EF loop
Mann– Whitney U test. The spinal cords from one or two
To further define the location of a neutralization sitemice inoculated 6 weeks previously with wild-type or
of DAmAb1 in the VP 2 EF loop, we sequenced the whole
each of the mutant viruses were fixed in 4% paraformal-
coding region for VP2 from five DA isolates that had been
dehyde, embedded in Epon, and stained with toluidine
grown in the presence of DAmAb1. We compared theseblue.
sequences with the sequence from two wild-type viruses,
DAPW and DAFL3 (Table 2). DAPW, a wild-type virusAnalysis of virus growth
similar to the one used as the parent for the generation
Viruses were tested for in vitro growth with one-step of the DAmAb1 escape mutant viruses, had evidence of
growth curves. Viruses were adsorbed onto petri dishes nucleotides coding for both a Thr and Ala at VP2 148
of BHK-21 cells for 1 hr at a multiplicity of infection of and for both a Gly and Ser at VP2 162, suggesting a
10. The monolayers were washed and scraped at 3, 6, mixed population of virus; in contrast, DAFL3 virus had
9, and 14 hr after infection. Cells and supernatants were coding sequence for a Thr at VP2 148 and Gly at VP2 162.
assayed for infectivity by means of a plaque assay on In comparison to DAFL3 virus, all five DAmAb1 escape
BHK-21 cells. mutant viruses had changes of VP2 148 from Thr to Ala
Viruses were tested for in vivo growth by assaying and of VP2 162 from Gly to Ser; we suspect that these
virus infectivity in brains from three mice inoculated with differences from DAFL3 virus were not important in resis-
wild-type or each of the mutant viruses 1 week PI. The tance to DAmAb1 since they were also present in DAPW
brain was homogenized into a 20% solution in Hank’s- virus. When compared to DAPW and DAFL3 virus, four
buffered saline solution and assayed by means of plaque of five of the mutant viruses had a change in VP2 143
assay. from Gly to Asp, while the fifth mutant had a VP2 173 Thr
to Phe change (Table 2). The importance of all of these
Analysis of viral genome persistence mutations with respect to virus neutralization was tested,
as described below.To investigate virus persistence, RNA was extracted
from the spinal cords of two or three mice from each
DAVP2 143 and DAVP2 173 are part of the DAmAb1group inoculated with either wild-type or mutant virus 6
neutralization siteweeks previously. An RT reaction was performed with a
random hexamer primer (Promega, Madison, WI). The RT As noted above, there were differences in amino
acids in the VP2 EF loop found in escape mutant vi-products were amplified by PCR with two primers that
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ruses resistant to DA virus when compared to one or
both wild-type viruses. In order to clarify the impor-
tance of particular residues in the DA neutralization
site, the nucleotide changes were separately intro- FIG. 4. RT-PCR of RNA extracted from the spinal cords of mice
inoculated 6 weeks previously with wild-type or mutant virus. RT-PCRduced into pDAFL3 to generate DA-VP2-143 (Asp), DA-
was performed as described under Materials and Methods. A represen-VP2-148 (Ala), DA-VP2-162 (Ser), and DA-VP2-173 (Phe)
tative agarose gel shows amplified products using DA VP2-specificmutant viruses. These mutant viruses were then tested
primers (above) and HPRT primers (below) for samples from mice inoc-
in a neutralization test (Table 1). DA-VP2-143 (Asp), ulated with: 141  (DA-VP2-141[Asn]), 143  (DA-VP2-143[Asp]), 148
DA-VP2-173 (Phe), and, as previously noted, DA-VP2  (DA-VP2-148[Ala]), 162  (DA-VP2-162[Ser]), 173  (DA-VP2-
173[Phe]). N indicates a negative RT-PCR control which contains no141 (Asn) viruses, failed to be neutralized by DAmAbI,
template.suggesting that both DAVP2-143 Gly and VP2-173 Thr
in addition to VP2-141 (Lys) are part of a neutralizing
site of DAmAb1. In contrast, both DA-VP2-148 (Ala)
None of 22 mice inoculated with DA-VP2-141 (Asn) andand DA-VP2-162 (Ser) were neutralized by DAmAb1,
none of 8 mice inoculated with DA-VP2-173 (Phe) virusindicating that VP2-148 Thr/Ala and VP2-162 Gly/Ser
had significant white matter pathology. Only occasionalare not part of a neutralizing site of DAmAb1.
mice inoculated with these two mutant viruses had mini-
mal meningitis or very infrequent small inflammatory cellVirus infectivity
infiltrates of the parenchyma (Table 4, Figs. 3b and 3c).
We compared the in vitro and in vivo infectivity of the The minimal white matter pathology seen following DA-
mutant viruses with wild-type virus. The plaque size of VP2-141 (Asn) virus infection was of special note since
the wild-type and mutant viruses was similar in size and animals were inoculated with more than 10-fold more
small. The in vitro one-step growth curves for all the PFU of this mutant virus than with the other viruses.
mutants (Fig. 2) was equal to or enhanced compared to Similar results were obtained from an additional two
the wild-type DAFL3 virus, except in the case of DA-VP2- other DA-VP2-141 (Asn) mutant viruses, derived from
141 (Asn) virus. In contrast to DAFL3 virus, DA-VP2-141 separate cDNA clones.
(Asn) virus had a slightly decreased growth at 3 and 7 Data from Epon-embedded sections of spinal cords
hr, a greater level of growth at 9 hr, and an equivalent was consistent with the above results. Mice inoculated
level of growth at 12 hr (Fig. 2); these differences were with DAFL3 and DA-VP2-143 (Asn) viruses demonstrated
not thought to represent any in vitro growth defect of the demyelination. Small areas of infiltrated macrophages
mutant virus. One week PI, brains from mice inoculated and inflammatory cells from animals inoculated with DA-
with the different viruses had a similar level of infectivity VP2-141 had evidence of some demyelination; however,
(Table 3). These results suggested that mutant viruses these areas were extremely infrequent. Two of two DA-
did not have a specific defect in growth in vitro or in the VP2-173 (Phe)-inoculated mice failed to demonstrate any
brain. evidence of demyelination, presumably because these
regions were so difficult to find.
The role of DA-VP2-141 and the surrounding region in The above findings were supported by studies with
disease phenotype DAmAb1 escape mutant viruses. DAmAb1 escape mu-
tant virus 5, which has VP2 173 (Phe) (as well as VP2-Wild-type and mutant DA viruses were inoculated intra-
148 [Ala] and 162 [Ser]) failed to demonstrate any whitecerebrally into 3-week-old SJL/J mice, and animals were
matter disease at 6 weeks PI, while DAmAb1 escapesacrificed at 6 weeks PI (Fig. 1, Table 4). As expected,
mutant viruses 1– 4, which have VP2 143 (Asp) (as well asall but 1 of 15 mice infected with wild-type DAFL3 virus
VP2 148 [Ala], and 162 [Ser]) demonstrated white matterhad moderate – severe pathological changes (greater
destruction and meningitis (data not shown).than or equal to 2), with white matter disruption and
In order to determine whether virus persisted we ana-lymphocyte infiltration of the spinal cord (Fig. 3a, Table
lyzed spinal cords from inoculated animals for the pres-4). A similar white matter disease pathology was seen
ence of viral genome by RT-PCR. Viral genome persistedin most of the animals inoculated with DA-VP2-143 (Asp),
in the spinal cord of mice inoculated by DA-VP2-141DA-VP2-148 (Ala), and DA-VP2-162 (Ser) viruses (Fig. 1,
(Asn), DA-VP2-143 (Asp), DA-VP2-148 (Ala), DA-VP2-162Table 4); the mean degree of pathology was lower for
(Ser), (Fig. 4); and DA wild-type viruses, the presence ofthe first two mutants than that seen with wild-type virus
the appropriate mutation in the viral genome-amplifiedor DA-VP2-162 (Ser) virus (Table 4); however, it was clear
products was confirmed by sequencing studies. In con-that these mutant viruses were capable of producing
trast, RNA extracted from the spinal cords of mice inocu-significant white matter disease. These results were in
lated 6 weeks previously with DA-VP2-173 (Phe) virusmarked contrast with those seen following inoculation
with DA-VP2-141 (Asn) and DA-VP2-173 (Phe) viruses. showed no evidence of viral genome. The absence of
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amplification was not related to the primers used for Although three DA residues are part of the DAmAb1
PCR since the same primers efficiently amplified tissue neutralizing site in the EF loop, they do not have a similar
culture stocks of DA-VP2-173 (Phe) virus as well as brain role in determining disease phenotype. Mice inoculated
tissue from mice infected 1 week previously with the with DA-VP2-143 (Asp) virus showed white matter pathol-
mutant. ogy with virus persistence similar to that seen in mice
inoculated with wild-type virus. DA-VP2-173 (Phe) virus
DISCUSSION neither persisted nor induced demyelination at 6 weeks
PI. DA-VP2-141 (Asn) virus persisted in the spinal cordTMEV is of special interest to virologists because of
for 6 weeks PI; however, this mutant virus induced signifi-its unusual disease phenotype. TO subgroup strains,
cantly less late white matter pathology than wild-typesuch as DA, persist in the CNS for the whole life of
virus. The persistence of DA-VP2-141 (Asn) in the ab-the mouse and appear to have a restricted infection in
sence of significant white matter disease is surprising;glial cells and macrophages. In addition, DA-induced
it may be that there is an insufficient amount of the virusdemyelinating disease serves as an experimental
to induce demyelination or that the virus is located inmodel of MS: both disease processes have a similar
different neural cells than is the case with wild-type virus.white matter pathology, and the immune system ap-
The diversity and complexity of disease phenotype pre-pears to contribute to demyelination in both. A goal of
sumably reflects the varied effects of the mutated aminoour work is to identify TMEV disease determinants and
acid residue on the three-dimensional structure of theto characterize the anti-TMEV immune response in or-
viral capsid. This variation of disease phenotype may beder to better understand the pathogenesis of TMEV-
responsible for our finding that DA-VP2-143 (Asp) andinduced disease, as well as MS.
DA-VP2-148 (Ala) viruses produce white matter pathologyPrevious investigations of DA virus mutants generated
that is significant in degree, but attenuated compared toin the presence of various neutralizing mAbs have proven
that seen with wild-type virus. Interestingly, the particularvaluable in the identification of neutralizing sites on the
amino acid residues that constitute poliovirus type 1 neu-virus as well as molecular determinants of TMEV-in-
tralization antigenic site 1 (VP1 94-102 in the BC loop)duced disease. We now show that DA amino acid 141
also have a very variable effect on mouse neurovirulenceLys, 143 Gly, and 173 Thr in the VP2 EF loop are part of
(Couderc et al., 1991).a neutralization site. We also tested isolates of GDVII
In contrast to DA-VP2-141 (Asn) virus, TMDA virusvirus that were grown in the presence of GDVII mAb4
(which is derived from an infectious cDNA clone of DA141and mAb6 (both of which share the same neutralizing
by Brahic and colleagues (Jarousse et al., 1994)) is re-site on GDVII subgroup strains (Nitayaphan et al., 1985))
ported to have demyelinating activity although it also hasfor the presence of a mutation in the EF loop (data not
the critical Asn at VP2. Presumably, DA-VP2-141 (Asn) andshown). All three GDVII escape mutants that were tested
TMDA have another sequence difference(s) that modu-had a change in wild-type GDVII VP2 142 from Ser to
lates the demyelinating activity. This difference may residePhe, suggesting that, like DAmAb1, GDVII mAb4/6 have
in the 1B-2A segment, as suggested by the fact that thea neutralization site on the TMEV VP2 EF loop; however,
demyelinating activity of GD1B-2A/DAFL3 recombinant vi-different amino acid residues presumably confer TO or
rus appears to be modulated by an interaction of thisGDVII subgroup specificity on these mAbs. In the case
segment with the VP2 141 amino acid residue.of poliovirus type 1, VP2 142 in the EF loop is similarly
Our results are more readily interpreted in the contextpart of a neutralization site (and affects mouse neuroviru-
lence) (Couderc et al., 1991). of the known three-dimensional structure of the DA virus
FIG. 5. Mutations found in DA escape mutant viruses resistant to neutralizing mAbs mapped onto the X-ray crystal structure of the capsid of DA
strain. (A) Color-coded spheres mark the locations of the X-ray crystal structure of the TMEV capsid. The surface features of the virus are highlighted
by coloring the trace in a continuous spectrum from dark blue (low radius) to white (high radius). Features at a radius below 135 A˚ disappear into
the black background. The spheres represent amino acid residues that have been mutated to escape neutralization by TMEV mAbs. The colors of
the labels define the color-coding of the spheres. The larger spheres mark sites where single amino acid substitutions have been shown to attenuate
the ability of DA virus to persist and cause demyelination, while mutation at the sites marked by the smaller spheres do not (see text). Note that
residue 268 of VP1 is not marked with a large sphere in this panel or in B because its precise location is unknown [since the C-terminus of VP1
(residues 257– 274) is disordered and therefore not visible in X-ray structure]; for this reason, the last visible residue of VP1 (256) is marked instead.
(B) Close-up stereo view shows the sites mutated in DA escape mutant viruses resistant to TMEV neutralizing mAbs in one of the 60 protomers
comprising the capsid. The color coding of the spheres is as in A, with the larger spheres marking sites where individual amino acid substitutions
can affect the ability of the virus to persist and demyelinate. Each site is highly exposed on the capsid surface. VP 101 is located in the second
part of the CD loop of VP1. All of the VP2 residues are in the EF loop of VP2. VP2 141 is located at each point of the prominent star-shaped plateaus
at the fivefold symmetry axes (A). Residues 143 and 148 of VP1 are also near the tips of the star. Residue 173 of VP2 and residue 101 of VP1 are
located near each other at the edge of the plateau, overlooking the large depression (pit) spanning the twofold axis. Residue 162 of VP2 is located
at a lower radius, about halfway down the slope connecting the bottom of the depression and the edge of the plateau.
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Colston, E. M., and Racaniello, V. R. (1995). Poliovirus variants selected(Fig. 5). Neutralizing antibody determinants of picornavi-
on mutant receptor-expressing cells identify capsid residues thatruses are generally, but not always, located on the outer
expand receptor recognition. J. Virol. 69, 4823– 4829.
surface of the capsid (Page et al., 1985; Li et al., 1994). Couderc, T., Guedo, N., Calvez, V., Pelletier, I., Hogle, J., Colbere-Gara-
Not surprisingly, all of the amino acids presently impli- pin, F., and Blondel, B. (1994). Substitutions in the capsids of poliovi-
rus mutants selected in human neuroblastoma cells confer on thecated in DA virus neutralization (reviewed in Roos and
Mahoney Type 1 strain a phenotype neurovirulent in mice. J. Virol.Casteel, 1992) are also exposed on the capsid surface
68, 8386– 8391.where they are readily accessible to antibodies: VP1 101
Couderc, T., Martin, A., Wychowski, C., Girard, M., Horaud, F., and
is in the CD loop of VP1; VP2 141, 143, and 173 are in Crainic, R. (1991). Analysis of neutralization-escape mutants selected
the EF loop of VP2; and VP1 268 is in the disordered from a mouse virulent type 1/type 2 chimeric poliovirus: identification
of a type 1 poliovirus with antigenic site 1 deleted. J. Gen. Virol. 72,carboxyl terminus of VP1, which, although not visible in
973–977.the crystallographic electron density map, is definitely
Fu, J., Stein, S., Rosenstein, L., Bodwell, T., Routbort, M., Semler, B. L.,exposed on the surface (Fig. 5).
and Roos, R. P. (1990). Neurovirulence determinants of genetically
All of the residues of DA that have been identified engineered Theiler’s viruses. Proc. Natl. Acad. Sci. USA 87, 4125–
as neutralization epitopes cluster around a depression 4129.
Grant, R. A., Filman, D. J., Fujinami, R. S., Icenogle, J. P., and Hogle,between the arms of the star-shaped plateaus that domi-
J. M. (1992). Three-dimensional structure of Theiler’s virus. Proc. Natl.nate the surface of the capsid (Fig. 5A). This region,
Acad. Sci. USA 89, 2061–2065.which consists mainly of the exposed surface of VP3,
Jarousse, N., Grant, R. A., Hogle, J. M., Zhang, L., Senkowski, A., Roos,
has been called the ‘‘pit’’ by Luo et al. (1992). The pit is R. P., Michiels, T., Brahic, M., and McAllister, A. (1994). A single
actually part of a larger depression that spans the twofold amino acid change determines persistence of a chimeric Theiler’s
virus. J. Virol. 68, 3364– 3368.icosahedral symmetry axes (Grant et al., 1992). The pit
Li, Q., Gomez-Yafal, A., Lee, Y. M-H., Hogle, J., and Chow, M. (1994).region has been proposed to be the TMEV receptor bind-
Poliovirus neutralization by antibodies to internal epitopes of VP4ing site based on the previously observed clustering of
and VP1 results from reversible exposure of these sequences at
important sites in the area (Grant et al., 1992; Jarousse physiological temperature. J. Virol. 68, 3865–3970.
et al., 1994; Luo et al., 1992). Although there is no direct Lipton, H. L. (1975). Theiler’s virus infection in mice: an unusual biphasic
process leading to demyelination. Infect. Immun. 11, 1147– 1155.evidence for the interaction of the cellular receptor with
Lipton, H. L., and Dal Canto, M. C. (1978). The TO strains of Theiler’sthe bottom of the pit, the location of VP1 101 and VP2
virus cause ‘‘slow virus-like’’ infection in mice. Ann. Neurol. 6, 25 –141 and 173 at the edge of the plateau overlooking the
28.
pit and the emergence of the disordered carboxyl termi- Luo, M., He, C., Toth, K. S., Zhang, C. X., and Lipton, H. L. (1992). Three-
nus of VP1 (including VP1 268) from the bottom of the dimensional structure of Theiler murine encephalomyelitis virus
(BeAn strain). Proc. Natl. Acad. Sci. USA 89, 2409– 2413.pit coupled with data demonstrating that mutations in
McAllister, A., Tangy, F., Aubert, C., and Brahic, M. (1989). Molecularthese residues induce a change in disease phenotype
cloning of the complete genome of Theiler’s virus, strain DA, and(Zurbriggen et al., 1991; Roos et al., 1989b) suggest that
production of infectious transcripts. Microb. Pathog. 7, 381–388.
the structure in this area is critically important in de- Martin, A., Wychowski, C., Couderc, C., Crainic, R., Hogle, J., and Girard,
termining the pathogenesis of TMEV infection. Structural M. (1991). Engineering a poliovirus type 2 antigenic site on a type 1
capsid to study determinants. EMBO J. 7, 2839– 2847.alterations in this area allow the virus to escape neutral-
Murray, M. G., Bradley, J., Yang, X.-F., Wimmer, E., Moss, E. G., andization and presumably also disrupt virus – receptor inter-
Racaniello, V. R. (1988). Poliovirus host range is determined by aactions that control tissue tropism in the infected CNS.
short amino acid sequence in neutralization antigenic site 1. Science
Similarly, in poliovirus, amino acid residues that are 241, 213–215.
known to constitute neutralization sites also play a role Nitayaphan, S., Toth, M., and Roos, R. P. (1985). Neutralizing mono-
clonal antibodies to Theiler’s murine encephalomyelitis Virus. J. Virol.in the recognition and binding of the receptor (Colston
53, 651–657.et al., 1995; Couderc et al., 1994, 1991; Martin et al., 1991;
Ohara, Y., Senkowski, A., Fu, J., Klaman, L., Goodall, J., Toth, M., andMurray et al., 1988). The imperfect congruence between
Roos, R. P. (1988). Trypsin-sensitive neutralization site on VP1 ofTMEV sites critical in neutralization and in disease phe- Theiler’s murine encephalomyelitis viruses. J. Virol. 62, 3527– 3529.
notype suggests that the antibody-binding sites only Page, G. S., Mosser, A. G., Hogle, J. M., Filman, D. J., Rueckert, R. R., and
Chow, M. (1988). Three-dimensional structure of poliovirus serotype Ipartly overlap those that affect receptor binding.
neutralizing determinants. J. Virol. 62, 1781–1794.
Pritchard, A. E., Jensen, K., and Lipton, H. L. (1993). Assembly of Theil-ACKNOWLEDGMENTS
er’s virus recombinants used in mapping determinants of neuroviru-
lence. J. Virol. 67, 3901–3907.The secretarial assistance of Ms. Ellie Orr is appreciated. This work
was supported by grants from the National Multiple Sclerosis Society Reiner, S. L., Zheng, S., Cory, D. B., and Locksley, R. M. (1993). Con-
structing polycompetitor cDNAs for quantitative PCR. J. Immunol.and the National Institutes of Health.
Methods 165, 37 – 46.
Roos, R. P., and Casteel, M. C. (1992). Determinants of neurologicalREFERENCES
disease induced by Theiler’s murine encephalomyelitis virus. In ‘‘Mo-
lecular Neurovirology: Pathogenesis of Central Nervous System In-Boege, U., Kobasa, D., Onodera, S., Parks, G. D., Palmenberg, A. C., and
Scraba, D. G. (1991). Characterization of Mengo virus neutralization fections’’ (R. P. Roos, Ed.), pp. 283–318. Humana Press, Totowa, NJ.
Roos, R. P., Stein, S., Ohara, Y., Fu, J., and Semler, B. L. (1989a). Infec-epitopes. Virology 181, 1 – 13.
AID VY 8288 / 6a26$$$123 11-14-96 10:47:54 viras AP: Virology
337DA VP2 NEUTRALIZATION SITE AND DISEASE DETERMINANTS
tious cDNA clones of the DA strain of Theiler’s murine encephalomy- the complete genome of Theiler’s virus, strain GDVII, and production
of infectious transcripts. J. Virol. 63, 1101–1106.elitis virus. J. Virol. 63, 5492– 5496.
Roos, R. P., Stein, S., Routbort, M., Senkowski, A., Bodwell, T., and Zhang, L., Sato, S., Kim, J. I., and Roos, R. P. (1995). Theiler’s virus as
a vector for foreign gene delivery. J. Virol. 69, 3171– 3175.Wollmann, R. (1989b). Theiler’s murine encephalomyelitis virus neu-
tralization escape mutants have a change in disease phenotype. J. Zhang, L., Senkowski, A., Shim, B., and Roos, R. P. (1993). Chimeric
cDNA studies of Theiler’s murine encephalomyelitis virus neuroviru-Virol. 63, 4469–4473.
Tangy, F., McAllister, A., Aubert, C., and Brahic, M. (1991). Determinants lence. J. Virol. 67, 4404–4408.
Zurbriggen, A., Thomas, C., Yamada, M., Roos, R. P., and Fujinami, R. S.of persistence of demyelination of the DA strain of Theiler’s virus
are found only in the VP1 gene. J. Virol. 65, 1616– 1618. [Author’s (1991). Direct evidence of a role for amino acid 101 of VP-I in central
nervous system disease in Theiler’s murine encephalomyelitis viruscorrection, 67, 2427, 1993.]
Tangy, F. A., McAllister, A., and Brahic, M. (1989). Molecular cloning of infection. J. Virol. 65, 1929–1937.
AID VY 8288 / 6a26$$$124 11-14-96 10:47:54 viras AP: Virology
